Is it time to target no evident disease activity (NEDA) in multiple sclerosis?

The management of multiple sclerosis is becoming increasingly complex with the emergence of new and more effective disease-modifying therapies (DMT). We propose a new treatment paradigm that individualises treatment based on a choice between two interchangeable therapeutic strategies of maintenance-...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Multiple sclerosis and related disorders Ročník 4; číslo 4; s. 329 - 333
Hlavní autoři:	Giovannoni, Gavin, Turner, Benjamin, Gnanapavan, Sharmilee, Offiah, Curtis, Schmierer, Klaus, Marta, Monica
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Netherlands Elsevier B.V 01.07.2015
Témata:	Algorithms Disease activity free Disease modifying therapy Disease Progression Humans Magnetic Resonance Imaging Multiple sclerosis Multiple Sclerosis - pathology Multiple Sclerosis - physiopathology Multiple Sclerosis - therapy NEDA Neurology No evident disease activity Precision Medicine - methods Treating to target Treatment Outcome NEDA Disease modifying therapy Multiple sclerosis Disease activity free No evident disease activity Treating to target
ISSN:	2211-0348, 2211-0356, 2211-0356
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!